Banque Cantonale Vaudoise Vaxart, Inc. Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$4.29 - $6.64 $8,151 - $12,616	-1,900 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$6.67 - $9.8 $246,790 - $362,600	-37,000 Reduced 95.12%	1,900 $15,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $187,220 - $398,860	37,000 Added 1947.37%	38,900 $291,000
Q1 2021 May 11, 2021	BUY	$5.64 - $23.33 $10,716 - $44,327	1,900 New	1,900 $11,000

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.